Drug delivery to the cochlea after implantation: consideration of the risk factors
Carolyn Garnham(MED-EL (Austria)), F Beal(MED-EL (Austria)), C. Jolly(MED-EL (Austria)), G Reetz(MED-EL (Austria)), James D. Miller(Wake Forest University), Alec N. Salt(Turner Consulting Group (United States))
Cited by 3
Related Papers
Cochlear implant electrode design for safe and effective treatment
|Frontiers in Neurology|2024|28
Drug delivery to the cochlea after implantation: consideration of the risk factors
|Cochlear Implants International|2005|15
Reducing Auditory Nerve Excitability by Acute Antagonism of Ca2+-Permeable AMPA Receptors
|Frontiers in Synaptic Neuroscience|2021|12